Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen [Phase 4]
Phase 4 study comparing stepwise addition of insulin aspart to a complete basal-bolus regimen in type 2 diabetes reports efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes [NA]
A completed clinical trial compared advanced medical therapy alone versus advanced medical therapy plus bariatric surgery for resolving Type…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance [Phase 2]
Phase 2 clinical trial assessing insulin-sensitizer therapy on atherothrombotic and inflammatory markers in people with insulin resistance a…
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: Proteomics Study of Gastric Bypass Surgery to Treat Type 2 Diabetes Mellitus
This entry describes a clinical trial investigating proteomic changes associated with gastric bypass surgery as a treatment for type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of Albuminuria
This completed clinical trial examined serum 1,25-dihydroxyvitamin D levels in patients with type 2 diabetes and varying levels of albuminur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance [Phase 1]
A Phase 1 clinical trial by Mayo Clinic investigating insulin receptor substrate 1 (IRS-1) regulation in insulin resistance in Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Optimizing Audit and Feedback for Primary Care [NA]
This document reports a completed clinical trial investigating methods to optimize audit and feedback in primary care.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride [Phase 3]
A Phase 3 trial (CANTATA-SU) evaluating canagliflozin added to metformin versus glimepiride as add-on therapy in adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy [Phase 3]
Phase 3 study assessing linagliptin 5 mg once daily in type 2 diabetes patients with inadequate glycemic control on metformin; results were …
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial [Phase 3]
The Phase 3 CANTATA-M trial evaluating canagliflozin as monotherapy in adults with Type 2 diabetes has completed, and results were posted in…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men [NA]
This clinical trial update describes a completed study investigating whether Vitamin D supplementation affects glucose and insulin metabolis…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluating the efficacy and safety of MP-513 in adults with Type 2 diabetes. The results were posted in 2013.
-
FDA label_change · 2013-05-31FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-05-31FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-05-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action authorizes changes to the produ…
-
FDA approval · 2013-05-30FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin submitted by Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea) [Phase 3]
Phase 3 trial update on canagliflozin in combination with metformin and a sulfonylurea for Type 2 diabetes, with results posted after study …
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 safety and efficacy data for canagliflozin in older adults (55-80) with Type 2 diabetes have been completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of JNJ-28431754 in patients with Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic study to characterize blood levels of canagliflozin (JNJ-28431754) in adults with Type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting [Phase 4]
Phase 4 clinical trial update showing termination of a real-world study comparing adding a single injection of Apidra to once-daily Lantus v…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes. [Phase 3]
Phase 3 trial results evaluate the efficacy of alogliptin in combination with pioglitazone in patients with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment [Phase 3]
This is a Phase 3 trial evaluating the efficacy, safety, and tolerability of canagliflozin in adults with type 2 diabetes mellitus and moder…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus [Phase 1]
This Phase 1 two-part single ascending-dose study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of DS-7309 in he…